Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-06

Clinical Trial Update: Tolerability and Efficacy of Artemether-Lumefantrine Versus Artesunate + Amodiaquine in Zanzibar [Phase 4]

View source ↗

Summary

Phase 4 trial comparing tolerability and efficacy of artemether-lumefantrine versus artesunate + amodiaquine for Plasmodium falciparum malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemether-lumefantrine (artemether and lumefantrine)
  • Artesunate-amodiaquine (artesunate-amodiaquine)

Snippet

Sponsor: Professor Anders Björkman | Conditions: Plasmodium Falciparum Malaria | Phase 4 | Status: COMPLETED